世界のデジタル治療市場2021-2028:用途別(糖尿病、肥満、CVD、CNS疾患、呼吸器疾患、禁煙)、最終用途別(患者、供給者、支払者、雇用者)

◆英語タイトル:Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation), By End-use (Patients, Providers, Payers, Employers), And Segment Forecasts, 2021 - 2028
◆商品コード:GV21AR002
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年4月15日
◆ページ数:90
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界のデジタル治療市場規模が2028年までに191億ドルに達すると予測しています。2021年から2028年までに年平均23.1%成長する見通しです。本市場調査レポートでは、デジタル治療の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、用途別(糖尿病、肥満、心血管疾患(CVD)、中枢神経系(CNS)疾患、呼吸器疾患)分析、最終用途別(患者、供給者、支払者、雇用者、その他)分析、地域別分析、競争状況・企業情報などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界のデジタル治療市場規模:用途別(糖尿病、肥満、心血管疾患(CVD)、中枢神経系(CNS)疾患、呼吸器疾患)
・世界のデジタル治療市場規模:最終用途別(患者、供給者、支払者、雇用者、その他)
・世界のデジタル治療市場規模:地域別
・競争状況・企業情報
【レポートの概要】

Digital Therapeutics Market Growth & Trends

The global digital therapeutics market size is anticipated to reach USD 19.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 23.1% from 2021 to 2028. The key drivers for this growth include increasing incidence of chronic diseases, digitization, demand for innovative and affordable healthcare, and government initiatives.

Digital health went from novel to necessity during 2020. It swept through almost every healthcare domain as adoption peaked, accelerated by the COVID-19 pandemic. This included telehealth, telemedicine, digital pathology, triage solutions, mhealth, as well as digital therapeutics. Omada Health, Inc., a digital therapeutics provider, leveraged the gaps in care due to COVID-19 to provide extra support and guidance from its licensed specialists to those who had their doctor’s appointments deferred indefinitely. The company also helped primary care providers, therapists, endocrinologists, and cardiologists convert their practices to telehealth through enhanced education, psychosocial support, and remote monitoring.

In response to COVID-19 and its repercussions on mental health, the FDA released guidelines expanding and promoting the scope of digital health therapeutic devices for mental health conditions. Rising initiatives by public and private players is another factor expected to propel the market growth. For instance, in June 2020, Akili Interactive Labs, Inc. received the CE mark for its digital therapeutic software for the treatment of ADHD called EndeavorRx.

With an increase in internet usage and dependency on smartphones, digital therapeutics is set to register continued growth over the forecast period. This is owing to increased demand for creative and innovative treatment options that could be used remotely by patients. In February 2021, SilverCloud partnered with Cerner Corporation to integrate its virtual mental health platform with the latter’s electronic health records. With this, SilverCloud intended to scale the delivery of evidence-based mental health treatment while improving patient outcomes and lowering the cost of care.

Digital Therapeutics Market Report Highlights

• The diabetes segment is expected to hold the largest market share by application in 2020 and is expected to witness the fastest CAGR during the forecast period. This is due to the increasing prevalence of the disease and the costs associated with the treatment. In June 2020, Welldoc received FDA clearance for an additional feature of its previously approved Software as a Medical Device (SaMD)-BlueStar Rx, for diabetic patients

• The obesity segment is also expected to account for a considerable market share over the forecast period due to the rising prevalence and costs associated with the condition. The adoption of digital therapeutics offers a reduction in healthcare costs associated with diseases like diabetes and obesity and is thus being used on an increasing scale

• The rising adoption of digital tracking, continuous monitoring, and management of physical activity and eating habits are other drivers propelling the growth of the market

• The patients segment accounted for the largest market share in the end-use segment in 2020 owing to the increasing incidence of chronic and lifestyle diseases

• In North America, the market accounted for the highest revenue share of more than 41.0% in 2020 owing to technological advancement and the presence of major players in the region

• In Asia Pacific, the market is expected to garner considerable growth during the forecast period owing to increasing digitization, adoption of advanced healthcare technologies, and rise in the number of chronic diseases

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Application
1.1.2 End-use
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
Chapter 2 Executive Summary
Chapter 3 Digital Therapeutics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing smartphone penetration
3.3.1.2 Cost-effectiveness of digital health technology for providers and patients
3.3.1.3 Increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restrain analysis
3.3.2.1 Reimbursement scenario
3.4 Digital Therapeutics: Market Analysis Tools: Porter’s Analysis
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Threat Of Substitutes
3.4.1.4 Threat Of New Entrants
3.4.1.5 Competitive Rivalry: Moderate
3.4.2 Digital Therapeutics Market: PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Economic Landscape
3.4.2.3 Social Landscape
3.4.2.4 Technological Landscape
3.4.2.5 Environmental Landscape
3.4.2.6 Legal Landscape
Chapter 4 Digital Therapeutics Market: Segment Analysis, By Application, 2016 – 2028 (USD Million)
4.1 Segment Dashboard
4.2 Global Digital Therapeutics Market, by Application, 2016 to 2028
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2028
4.3.1 Diabetes
4.3.1.1 Diabetes market, 2016 – 2028 (USD Million)
4.3.2 Obesity
4.3.2.1 Obesity market, 2016 – 2028 (USD Million)
4.3.3 Cardiovascular Diseases (CVD)
4.3.3.1 CVD market, 2016 – 2028 (USD Million)
4.3.4 Central Nervous System (CNS) Disease
4.3.4.1 CNS diseases market, 2016 – 2028 (USD Million)
4.3.5 Respiratory Diseases
4.3.5.1 Respiratory diseases market, 2016 – 2028 (USD Million)
4.3.6 Smoking Cessation
4.3.6.1 Smoking cessation market, 2016 – 2028 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2016 – 2028 (USD Million)
Chapter 5 Digital Therapeutics Market: Segment Analysis, By End Use, 2016 – 2028 (USD Million)
5.1 Segment Dashboard
5.2 Global Digital Therapeutics Market, by End Use, 2016 to 2028
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.3.1 Patients
5.3.1.1 Patients market, 2016 – 2028 (USD Million)
5.3.2 Providers
5.3.2.1 Providers market, 2016 – 2028 (USD Million)
5.3.3 Payers
5.3.3.1 Payers market, 2016 – 2028 (USD Million)
5.3.4 Employers
5.3.4.1 Employers market, 2016 – 2028 (USD Million)
5.3.5 Others
5.3.5.1 Others market, 2016 – 2028 (USD Million)
Chapter 6 Global Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, and By End Use
6.1 Global Digital Therapeutics Market: Regional Movement Analysis
6.2 North America
6.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.2.2 U.S.
6.2.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3 Europe
6.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3.2 U.K.
6.3.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3.3 Germany
6.3.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3.4 France
6.3.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.4.2 Japan
6.4.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.4.3 China
6.4.3.1. Market estimates and forecasts, 2016 – 2028 (USD Million)
6.4.4 India
6.4.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.5 Latin America
6.5.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.6 MEA
6.6.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.6.2 South Africa
6.6.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 7 Digital Therapeutics Market – Competitive Analysis & Company Profiles
7.1 Market Participation Categorization
7.1.1 Market Leaders
7.1.1.1 Company market position/share analysis, 2020
7.1.2 Innovators
7.2 Major Deals & Strategic Alliances Analysis
7.2.1 List Of private companies
7.3 Company Profiles
7.3.1 Omada Health, Inc.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic initiatives
7.3.2 WellDoc Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic initiatives
7.3.3 2 Morrow, Inc.
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Livongo Health
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Propeller Health
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Twinehealth
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Canary Health, Inc.
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Mango Health, Inc.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Noom Health, Inc.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Pear Therapeutics
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives

List of Tables

Table 1. List of Abbreviations
Table 2. Factors used in segment share estimation
Table 3. List of secondary data sources
Table 4. List of emerging companies
Table 5. North America digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 6. North America digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 7. North America digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 8. U.S. digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 9. U.S. digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 10. Canada digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 11. Canada digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 12. Europe digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 13. Europe digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 14. Europe digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 15. Germany digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 16. Germany digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 17. U.K. digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 18. U.K. digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 19. France digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 20. France digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 21. Italy digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 22. Italy digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 23. Spain digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 24. Spain digital therapeutics market, by end-use, 2016 - 2028(USD Million
Table 25. Asia Pacific digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 26. Asia Pacific digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 27. Asia Pacific digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 28. China digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 29. China digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 30. India digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 31. India digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 32. Japan digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 33. Japan digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 34. Latin America digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 35. Latin America digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 36. Latin America digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 37. Brazil digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 38. Brazil digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 39. Mexico digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 40. Mexico digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 41. Argentina digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 42. Argentina digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 43. MEA digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 44. MEA digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 45. MEA digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 46. South Africa digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 47. South Africa digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 48. Saudi Arabia digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 49. Saudi Arabia digital therapeutics market, by end-use, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Commodity workflow analysis
Fig. 9 Digital therapeutics market revenue, 2016 - 2028 (USD Million)
Fig. 10 Digital therapeutics market snapshot
Fig. 11 Competitive insights
Fig. 12 Parent market outlook
Fig. 13 Ancillary Market Outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Digital therapeutics market dynamics
Fig. 16 Digital therapeutics market driver impact
Fig. 17 Digital therapeutics market restraint impact
Fig. 18 Market Participant Categorization
Fig. 19 Key Companies and strategies
Fig. 20 Company Market Share Analysis, 2020
Fig. 21 Company market position analysis
Fig. 22 Regional network map
Fig. 23 Digital therapeutics market application outlook: Key takeaways
Fig. 24 Digital therapeutics market: application movement analysis
Fig. 25 Global Diabetes market, 2016 - 2028 (USD Million)
Fig. 26 Global Obesity market, 2016 - 2028 (USD Million)
Fig. 27 Global CVD market, 2016 - 2028 (USD Million)
Fig. 28 Global Respiratory Diseases market, 2016 - 2028 (USD Million)
Fig. 29 Global Smoking Cessation market, 2016 - 2028 (USD Million)
Fig. 30 Global CNS Disease market, 2016 - 2028 (USD Million)
Fig. 31 Global Others market, 2016 - 2028 (USD Million)
Fig. 32 Digital therapeutics market end-use outlook: Key takeaways
Fig. 33 Digital therapeutics market: end-use movement analysis
Fig. 34 Global Patients market, 2016 - 2028 (USD Million)
Fig. 35 Global Providers market, 2016 - 2028 (USD Million)
Fig. 36 Global Payers market, 2016 - 2028 (USD Million)
Fig. 37 Global Employers market, 2016 - 2028 (USD Million)
Fig. 38 Global Others market, 2016 - 2028 (USD Million
Fig. 39 Digital therapeutics market Regional: Key takeaways
Fig. 40 Digital therapeutics market Regional outlook, 2020 & 2028
Fig. 41 North America Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 42 U.S. Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 43 Canada Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 44 Europe Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 45 U.K. Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 46 Germany Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 47 France Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 48 Italy Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 49 Spain Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 50 Asia Pacific Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 51 Japan Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 52 China Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 53 India Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 54 Latin America Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 55 Mexico Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 56 Brazil Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 57 Argentina Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 58 MEA Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 59 South Africa Digital therapeutics market, 2016 - 2028 (USD Million)
Fig. 60 Saudi Arabia Digital therapeutics market, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のデジタル治療市場2021-2028:用途別(糖尿病、肥満、CVD、CNS疾患、呼吸器疾患、禁煙)、最終用途別(患者、供給者、支払者、雇用者)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆